FDA Approves Companion Diagnostic for Colorectal Cancer Treatment
The FDA has approved a companion diagnostic for identifying BRAF V600E-mutant metastatic colorectal cancer patients eligible for encorafenib combination therapy.
Category: Colorectal
Colorectal
Latest
Colorectal
Latest
ColoHealth Blood Test Offers a Simpler First Step in Colorectal Cancer Screening
New Day Diagnostics has launched ColoHealth, a physician-mediated blood test for colorectal cancer screening.
Colorectal
Latest
Stool DNA Test Shows High Accuracy in Detecting Colorectal Cancer
Multitarget stool DNA testing is a highly sensitive, non-invasive method for colorectal cancer screening, offering a colonoscopy alternative.
AI Bowel Cancer Test Can Tell if Patients Need Chemotherapy
A new AI-based test assesses CD3 immune cells in early-stage bowel cancer tumors to predict recurrence risk.
Read More
Hot Spots to Improve Colorectal Cancer Screening in Hispanic/Latino Communities Identified
Researchers have identified geographic “hot spots” in the U.S. with low colorectal cancer screening rates among Hispanic/Latino communities.
Read More
At-Home Colon Cancer Screening Test Reduces Risk of Colorectal Cancer Death
A new study reveals that an at-home colorectal cancer screening test, FIT, can reduce the risk of colorectal cancer death by 33%.
Read More
Mainz Biomed Announces FDA Breakthrough Device Designation Submission for CRC Test
Mainz Biomed has applied for FDA Breakthrough Device Designation for its advanced non-invasive colorectal cancer screening test.
Read More
New Industry Collaboration Seeks to Advance Colorectal Cancer Screening
The new collaboration aims to enhance colorectal cancer (CRC) screening using advanced diagnostic platforms and novel biomarkers.
Read More
Mainz Biomed Awarded Poster of Distinction at Digestive Disease Week
Mainz Biomed unveiled findings of the eAArly DETECT study that demonstrated high sensitivity and specificity of their colorectal cancer test.
Read More
FDA Advisory Committee Panel Recommends Approval of Colorectal Blood Test
The FDA’s Medical Devices Advisory Committee recommended approval of Guardant Health’s Shield blood test for colorectal cancer screening.
Read More
Some Patients Repeat Fecal Tests to Delay Colonoscopy
A new study found that 7.4% of patients repeated fecal testing rather than proceeding directly to colonoscopy as guidelines recommend.
Read More
Choice of Tests Doubled Colorectal Cancer Screening
Offering a choice between colonoscopy and a take-home screening kit more than doubled colorectal cancer screening rates.
Read More
Mainz Biomed Colorectal Cancer Diagnostic Part of FDA Trial
Mainz Biomed N.V. announced results from a clinical study to evaluating integrating its portfolio into its colorectal cancer screening tool.
Read More
Mainz Biomed to Present Results of Colorectal Cancer Screening Study
Mainz Biomed will present the findings of a study that evaluated its multimodal screening test for the detection of colorectal cancer.
Read More
FDA Approves Geneoscopy’s Multi-Target Stool RNA Colorectal Cancer Test
Geneoscopy received U.S. FDA approval for ColoSense, a noninvasive colorectal cancer screening test that uses RNA biomarkers.
Read More
Researchers Identify the Critical Gap in Colorectal Cancer Screening
A significant gap exists in ensuring timely follow-up with colonoscopy after a positive stool test, hindering the effectiveness of screening.
Read More
How Effective are Blood Tests for Colorectal Cancer Screening?
New studies are cautioning against the use of blood tests to replace established colorectal cancer screening tests.
Read More
Next-Gen Stool DNA Test for Colorectal Cancer Has High Detection Rate
Researchers say the test has the best performance for the detection of both colorectal cancer and advanced precancerous polyps.
Read More